AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Igene Biotechnology, Inc.

$0 +$0.00 (+0.00%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0
Market Cap
15.65K
AVG Volume
65.32K
Trailing/Forward PE
-0.1/-
PEG ratio
0.01
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
02.5M5M7.5M10M08 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
10 Q34.8K
10 Q21.12M
10 Q12.72M
09 Q43.96M
09 Q35.34M
09 Q25.95M
09 Q16.01M
08 Q47.64M
08 Q38.55M
08 Q26.81M
Net Income (USD) · TTM
-4M-3M-2M-1M008 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
10 Q3-2.37M
10 Q2-1.63M
10 Q1-1.42M
09 Q4-140.75K
09 Q3-1.12M
09 Q2-2.03M
09 Q1-2.39M
08 Q4-3.99M
08 Q3-3.05M
08 Q2-2.83M
Operating Income (USD) · TTM
-3M-2M-1M008 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
10 Q3-2.33M
10 Q2-1.55M
10 Q1-1.33M
09 Q4-1.07M
09 Q3-1.94M
09 Q2-2.34M
09 Q1-2.15M
08 Q4-2.19M
08 Q3-894.67K
08 Q2-692.66K
EBITDA (USD) · TTM
-3M-2M-1M01M08 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
10 Q3-457.77K
10 Q2212.66K
10 Q173.33K
09 Q4139.46K
09 Q3-781.57K
09 Q2-1.63M
09 Q1-1.81M
08 Q4-2.08M
08 Q3-890.96K
08 Q2-592.04K
Cash Flows (USD) · TTM
-2M-1M01M2M08 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
10 Q3-1.67M
10 Q2-1.64M
10 Q1-172.46K
09 Q4-268.83K
09 Q3760.87K
09 Q21.36M
09 Q1-1.42M
08 Q4479.44K
08 Q31.51M
08 Q21.64M
EPS (USD) · TTM
-0.03-0.02-0.01008 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
10 Q3-0
10 Q2-0
10 Q1-0
09 Q4-0
09 Q3-0
09 Q2-0.01
09 Q1-0.02
08 Q4-0.03
08 Q3-0.03
08 Q2-0.03
Expenses (USD) · TTM
-1M01M2M3M4MR&DSG&ACapex08 Q208 Q308 Q409 Q109 Q209 Q309 Q410 Q110 Q210 Q3
IGNE Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
10 Q32.97M
10 Q23M
10 Q12.95M
09 Q43.25M
09 Q33.45M
09 Q23.53M
09 Q13.66M
08 Q43.66M
08 Q33.33M
08 Q22.98M
Free Cash Flow Yield
-10638.75%-10638.5%-10638.25%-10638%-10637.75%-10637.5%med -10638.64%Jan 25May 25Sep 25Jan 26May 26Sep 26
IGNE Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-10638.64%
Sep 26-10638.64%
Sep 26-10638.64%
Aug 26-10638.64%
Aug 26-10638.64%
Aug 26-10638.64%
Aug 26-10638.64%
Jul 26-10638.64%
Jul 26-10638.64%
Jul 26-10638.64%
Jul 26-10638.64%
Jul 26-10638.64%
Jun 26-10638.64%
Jun 26-10638.64%
Jun 26-10638.64%
Jun 26-10638.64%
May 26-10638.64%
May 26-10638.64%
May 26-10638.64%
May 26-10638.64%
May 26-10638.64%
Apr 26-10638.64%
Apr 26-10638.64%
Apr 26-10638.64%
Apr 26-10638.64%
Mar 26-10638.64%
Mar 26-10638.64%
Mar 26-10638.64%
Mar 26-10638.64%
Feb 26-10638.64%
Feb 26-10638.64%
Feb 26-10638.64%
Feb 26-10638.64%
Jan 26-10638.64%
Jan 26-10638.64%
Jan 26-10638.64%
Jan 26-10638.64%
Jan 26-10638.64%
Dec 25-10638.64%
Dec 25-10638.64%
Dec 25-10638.64%
Dec 25-10638.64%
Nov 25-10638.64%
Nov 25-10638.64%
Nov 25-10638.64%
Nov 25-10638.64%
Oct 25-10638.64%
Oct 25-10638.64%
Oct 25-10638.64%
Oct 25-10638.64%
Oct 25-10638.64%
Sep 25-10638.64%
Sep 25-10638.64%
Sep 25-10638.64%
Sep 25-10638.64%
Aug 25-10638.64%
Aug 25-10638.64%
Aug 25-10638.64%
Aug 25-10638.64%
Aug 25-10638.64%
Jul 25-10638.64%
Jul 25-10638.64%
Jul 25-10638.64%
Jul 25-10638.64%
Jun 25-10638.64%
Jun 25-10638.64%
Jun 25-10638.64%
Jun 25-10638.64%
May 25-10638.64%
May 25-10638.64%
May 25-10638.64%
May 25-10638.64%
May 25-10638.64%
Apr 25-10638.64%
Apr 25-10638.64%
Apr 25-10638.64%
Apr 25-10638.64%
Mar 25-10638.64%
Mar 25-10638.64%
Mar 25-10638.64%
Mar 25-10638.64%
Feb 25-10638.64%
Feb 25-10638.64%
Feb 25-10638.64%
Feb 25-10638.64%
Jan 25-10638.64%
Jan 25-10638.64%
Jan 25-10638.64%
Jan 25-10638.64%
Jan 25-10638.64%
Dec 24-10638.64%
Dec 24-10638.64%
Dec 24-10638.64%
Dec 24-10638.64%
Nov 24-10638.64%
Nov 24-10638.64%
Nov 24-10638.64%
Nov 24-10638.64%
Nov 24-10638.64%
Oct 24-10638.64%
Price to Sales
33.544.5med 3.26Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
IGNE Price to Sales by quarter
PeriodPrice to Sales
Sep 263.26
Sep 263.26
Sep 263.26
Aug 263.26
Aug 263.26
Aug 263.26
Aug 263.26
Jul 263.26
Jul 263.26
Jul 263.26
Jul 263.26
Jul 263.26
Jun 263.26
Jun 263.26
Jun 263.26
Jun 263.26
May 263.26
May 263.26
May 263.26
May 263.26
May 263.26
Apr 263.26
Apr 263.26
Apr 263.26
Apr 263.26
Mar 263.26
Mar 263.26
Mar 263.26
Mar 263.26
Feb 263.26
Feb 263.26
Feb 263.26
Feb 263.26
Jan 263.26
Jan 263.26
Jan 263.26
Jan 263.26
Jan 263.26
Dec 253.26
Dec 253.26
Dec 253.26
Dec 253.26
Nov 253.26
Nov 253.26
Nov 253.26
Nov 253.26
Oct 253.26
Oct 253.26
Oct 253.26
Oct 253.26
Oct 253.26
Sep 253.26
Sep 253.26
Sep 253.26
Sep 253.26
Aug 253.26
Aug 253.26
Aug 253.26
Aug 253.26
Aug 253.26
Jul 253.26
Jul 253.26
Jul 253.26
Jul 253.26
Jun 253.26
Jun 253.26
Jun 253.26
Jun 253.26
May 253.26
May 253.26
May 253.26
May 253.26
May 253.26
Apr 253.26
Apr 253.26
Apr 253.26
Apr 253.26
Mar 253.26
Mar 253.26
Mar 253.26
Mar 253.26
Feb 253.26
Feb 253.26
Feb 253.26
Feb 253.26
Jan 253.26
Jan 253.26
Jan 253.26
Jan 253.26
Jan 253.26
Dec 243.26
Dec 243.26
Dec 243.26
Dec 243.26
Nov 243.26
Nov 243.26
Nov 243.26
Nov 243.26
Nov 243.26
Oct 243.26
EV/EBITDA
0100200300med 172.85Apr 08Jun 08May 10Jul 10Sep 10Oct 10Dec 10
IGNE EV/EBITDA by quarter
PeriodEV/EBITDA
Dec 1066.67
Dec 1074.03
Dec 1066.67
Dec 1059.31
Nov 1055.63
Nov 1059.31
Nov 1055.63
Nov 1066.67
Oct 1074.03
Oct 1066.67
Oct 1060.05
Oct 1060.05
Oct 10103.48
Sep 10293.87
Sep 10144.68
Sep 10272.56
Sep 10208.62
Aug 10229.93
Aug 10229.93
Aug 10229.93
Aug 10229.93
Jul 10229.93
Jul 10187.31
Jul 10187.31
Jul 10187.31
Jul 10187.31
Jun 10106.15
Jun 10106.15
Jun 10106.15
Jun 10106.15
May 10106.15
May 1095.03
May 1095.03
May 1095.03
Apr 10183.96
Apr 10150.61
Apr 10150.61
Apr 10150.61
Apr 10161.73
Jun 08233.72
Jun 08239.14
Jun 08251.34
Jun 08239.14
May 08245.92
May 08245.92
May 08245.92
May 08245.92
May 08251.34
Apr 08251.34
Apr 08245.92
Apr 08245.92
Apr 08245.92
Price/Operating Cashflow
0200004000060000med 1.59Apr 08Jul 08Oct 08Feb 09May 09Dec 09Mar 10
IGNE Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Mar 1018.34
Mar 1016.67
Mar 1018.34
Mar 1016.67
Feb 1021.67
Feb 1016.67
Feb 1016.67
Feb 1016.67
Jan 109.67
Jan 109.67
Jan 109.67
Jan 1016.67
Dec 0916.67
Dec 095.83
Dec 095.83
Dec 095.83
Dec 097.78
Nov 097.78
Nov 0917.5
Nov 0926.25
Nov 093.89
Oct 093.11
Oct 098.26
Oct 098.75
Oct 099.82
Oct 099.82
Jun 0912.09
Jun 0912.09
Jun 0918.13
Jun 0912.09
May 0913.29
May 0913.29
May 0913.29
May 0916.92
May 0912.09
Apr 097.25
Apr 097.25
Apr 0912.09
Apr 0924.17
Mar 090.94
Mar 090.31
Mar 091.13
Mar 091.13
Feb 090.38
Feb 090.38
Feb 090.38
Feb 090.38
Jan 091
Jan 091.25
Jan 090.94
Jan 090.38
Jan 090.38
Dec 080.3
Dec 080.3
Dec 080.3
Dec 080.33
Nov 080.3
Nov 080.36
Nov 080.36
Nov 080.36
Oct 080.36
Oct 080.83
Oct 081.19
Oct 080.53
Oct 080.36
Sep 080.2
Sep 080.33
Sep 080.42
Sep 080.42
Aug 080.42
Aug 080.42
Aug 080.42
Aug 080.42
Aug 080.42
Jul 080.42
Jul 080.42
Jul 080.46
Jul 080.33
Jun 080.5
Jun 080.84
Jun 081.59
Jun 080.84
May 081.26
May 081.26
May 081.26
May 081.26
May 081.59
Apr 081.59
Apr 081.26
Apr 081.26
Apr 081.26
Jun 0748763.02
Jun 0748763.02
Jun 0744428.53
Jun 0759599.24
May 0732508.68
May 0732508.68
May 0721672.45
May 0721672.45
Apr 0736843.17
Igene Biotechnology, Inc.
IGNE
Stockpicker

Video analysis: IGNE

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.